Risedronate sodium
SIGMA/SML0650 - ≥97% (HPLC)
Synonym: P,P′-[1-Hydroxy-2-(3-pyridinyl)ethylidene]bis-phosphonic acid sodium; Sodium risedronate; [1-
CAS Number: 115436-72-1
Empirical Formula (Hill Notation): C7H10NO7P2 · Na
Molecular Weight: 305.09
Linear Formula: C7H10NO7P2 · Na
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C7H11NO7P2.Na/c9-7(16( |
| InChI key | DRFDPXKCEWYIAW-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [Na+].[P](=O)([O-])(O)[C@ |
| solubility | H2O: 5 mg/mL, clear (warmed) |
| storage temp. | room temp |
| Biochem/physiol Actions: | Risedronate sodium is a bisphosphonate bone resorption inhibitor. |
| Biochem/physiol Actions: | Risedronate sodium is a bisphosphonate bone resorption inhibitor. It has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent and is an inhibitor of farnesyl diphosphate (FPP) synthase, which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. Risedronate sodium has been used to treat postmenopausal osteoporosis and Paget′s disease. |
| Packaging: | 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 41106300 |


